pf-04136309
Showing 1 - 5 of 5
Osteoarthritis, Knee Trial in Korea, Republic of, United States (PF-04136309, Placebo)
Completed
- Osteoarthritis, Knee
- PF-04136309
- Placebo
-
DeLand, Florida
- +21 more
Jun 21, 2021
Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (PF-04136309, Nab-paclitaxel, Gemcitabine)
Terminated
- Metastatic Pancreatic Ductal Adenocarcinoma
- PF-04136309
- +2 more
-
Boston, Massachusetts
- +17 more
Feb 1, 2019
Healthy Trial in Brussels (PF-04136309)
Completed
- Healthy
- PF-04136309
-
Brussels, BelgiumPfizer Clinical Research Unit
Apr 9, 2018
Pancreatic Tumors Trial in Saint Louis (Oxaliplatin, Irinotecan, Leucovorin)
Completed
- Pancreatic Neoplasms
- Oxaliplatin
- +8 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 15, 2016
Hepatitis C, Chronic Trial in Worldwide (Placebo, PF-04136309)
Terminated
- Hepatitis C, Chronic
- Placebo
- PF-04136309
-
Hong KOng, Hong Kong
- +9 more
Mar 19, 2012